mc val cit pab

MC-Val-Cit-PAB 是一种组织蛋白酶可裂解的 ADC 接头，用于制备抗体-药物偶联物。

MC-Val-Cit-PAB-Amide-TLR7 agonist 4 TFA是MC-Val-Cit-PAB-Amide-TLR7 agonist 4的三氟乙酸盐形式。MC-Val-Cit-PAB-Amide-TLR7 agonist 4是HER2-TLR7和HER2-TLR8免疫激动剂复合物，通过激活TLR7和TLR8信号通路，增强免疫反应，具有潜在的抗肿瘤活性。

MC-Val-Cit-PAB-Auristatin E is an antibody-drug conjugate (ADC) linker compound featuring Auristatin E, a potent cytotoxic tubulin modifier, connected through the MC-Val-Cit-PAB linker, exhibiting significant antitumor activity.

MC-Val-Cit-PAB-carfilzomib is a potent antitumor drug-linker conjugate for antibody-drug conjugates (ADC), comprising the irreversible proteasome inhibitor carfilzomib, connected through the ADC linker MC-Val-Cit-PAB.

Mc-Val-Cit-PAB-Cl 是一种可切割的 ADC 接头，可用于偶联 MMAE 和抗体以形成抗体-MC-vc-MMAE。

MC-Val-Cit-PAB-clindamycin is an antibody-drug conjugate (ADC) linker that combines the potent antitumor properties of clindamycin, a protein synthesis inhibitor, with the ADC linker MC-Val-Cit-PAB, to enhance its ability to target and kill cancer cells effectively.

MC-Val-Cit-PAB-dimethylDNA31 is a drug-linker conjugate employed in antibody-drug conjugates (ADCs) that exhibits robust antitumor efficacy. This conjugate utilizes the ADC linker, MC-Val-Cit-PAB, to link to the potent antitumor agent dimethylDNA31. Notably, dimethylDNA31 also demonstrates significant bactericidal activity against both persister and stationary-phase Staphylococcus aureus.

MC-Val-Cit-PAB-duocarmycin is an antibody-drug conjugate (ADC) linker that combines duocarmycin, a potent DNA minor groove-binding alkylating agent, with an antitumor drug through the MC-Val-Cit-PAB linker, exhibiting significant antitumor activity.

MC-Val-Cit-PAB-Indibulin is an antitumor drug-linker conjugate for antibody-drug conjugates (ADCs), featuring the orally active tubulin assembly inhibitor, Indibulin, connected through the MC-Val-Cit-PAB ADC linker. This compound exhibits potent antitumor activity.

MC-Val-Cit-PAB-MMAF is an antibody-drug conjugate (ADC) component that exhibits antitumor properties through the action of the tubulin inhibitor, monomethyl auristatin F (MMAF), which is connected by a cathepsin-cleavable linker, MC-Val-Cit-PAB.

MC-Val-Cit-PAB-Retapamulin is a drug-linker conjugate for antibody-drug conjugates (ADC) that exhibits potent antitumor activity. This compound utilizes Retapamulin, a ribosome inhibitor, connected through the ADC linker MC-Val-Cit-PAB.

MC-Val-Cit-PAB-rifabutin is a drug-linker conjugate designed for antibody-drug conjugates (ADC), featuring the potent antitumor agent rifabutin (a DNA-dependent RNA polymerase inhibitor) connected through the MC-Val-Cit-PAB ADC linker. This configuration endows it with significant antitumor activity.

MC-Val-Cit-PAB-vinblastine is a potent antitumor drug-linker conjugate for Antibody-Drug Conjugates (ADC), featuring vinblastine (a microtubule protein inhibitor) connected through the MC-Val-Cit-PAB ADC linker.

MC-Val-Cit-PAB-Sunitinib 是由有效载荷Sunitinib与连接子组成的化合物。MC-Val-Cit-PAB-Sunitinib 适用于合成 HR97-Sunitinib。

MC-VAL-CIT-PAB-VX765 or MC-VAL-CIT-PABC-VX765 is a VX765 derivative that can be conjugated to antibodies, proteins, or polymers for targeted drug delivery. MC-Val- CIT -PAB is a cathepsin cleavable ADC connector, which has been widely used in the preparat

MC-Val-Cit-PAB (GMP)是 MC-Val-Cit-PAB 的 GMP 级别试剂。MC-Val-Cit-PAB 是一种组织蛋白酶可裂解的 ADC 接头，用于制备抗体-药物偶联物。

MC-Val-Cit-PAB-NH-C2-NH-Boc 为一种ADC连接子，能被cathepsin降解，适用于抗体药物偶联体（ADC）的合成。

MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) 是一种抗体-活性分子偶联物（ADC）的关键部分，由 DNA 拓扑异构酶 I 抑制剂 DX-8951 和组织蛋白酶敏感的连接子共同构成。

Mc-Val-Cit-PAB-Gefitinibchloride是一种担载EGFR酪氨酸激酶抑制剂Gefitinib的ADC活性分子连接子偶联物，由Gefitinib和专为ADC设计的连接子Mc-Val-Cit-PAB构成。

MC-Val-Cit-PAB-Ispinesib（Compound 509）为有效Eg5抑制剂，亦为点击化学试剂。

MC-D-Val-Cit-PAB-PNP是一种活性分子-接头-配体偶联物，用于研究癌症、自身免疫疾病和传染病。

MC-Val-D-Cit-PAB-PNP 是一种肽类linker，适用于抗体偶联活性分子（ADC）的合成。该化合物具备一个可与抗体结合的马来酰亚胺己酰基（Mc）和一个连接抗肿瘤化合物的对硝基苯酚（PNP）基团，属于可降解（cleavable）类型。

MC-Val-Cit-PAB-Amide-TLR7 agonist 4 Conjugate 是一种由 MC-Val-Cit-PAB-Amide 和-TLR7 agonist 4 链接而成的偶联物，可用于研究癌症。

MC-VC-PAB-DMEA-SN38 是一种硫醇反应型 Drug-linker,具有创新型高度稳定可降解连接子，SN-38 可抑制 DNA 和 RNA 合成的，常用于抗体-药物偶联物（ADC）的合成。